DPP4 and Hyperglycemia: AGSIs have been regarded as the most eminent hyperglycemia controlling agents along with other medications such as glucagon-like peptide 1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodium-glucose cotransporter-2 (SGL-2) inhibitors.